Oesophageal Cancer: ESMO Clinical Practice Guidelines

Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v50-v57 

Authors: F. Lordick, C. Mariette, K. Haustermans, R. Obermannová and D. Arnold

Oesophageal cancer is the 19th most common cancer in Europe and includes two main subtypes: oesophageal squamous cell carcinoma and oesophageal adenocarcinoma. Although squamous cell carcinoma accounts for ∼90% of cases of oesophageal cancer worldwide, mortality rates associated with oesophageal adenocarcinoma are rising and have surpassed those of squamous cell carcinoma in several regions in Europe. These updated ESMO guidelines include recommendations for diagnosis, staging and risk assessment and management of local/locoregional and advanced disease, as well as a personalised medicine synopsis and recommendations for follow-up, long-term implications and survivorship. 

Download the PDF from Annals of Oncology
Last update: 02 October 2013